Arrowhead Pharmaceuticals, Inc. today announced that the Chinese National Medical Products Administration (NMPA) has approved REDEMPLO® (plozasiran) for the reduction of triglyceride levels in adult ...

Arrowhead Pharmaceuticals said Tuesday that its gene-silencing drug candidate nearly doubled four-month weight loss ...

Arrowhead Pharmaceuticals, Inc. today announced that Health Canada has issued a Notice of Compliance (NOC) authorizing REDEMPLOtm (plozasiran), a small interfering RNA (siRNA) medicine, as an adjunct ...

Researchers reveal liquid structures on ultrafast timescales using a laser technique, unlocking new insights into molecular ...

Viruses occupy a central place in ecology and health, influencing the dynamics of terrestrial, aquatic, and managed ...

Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most known CRISPR systems target invading pathogens' DNA and chop it up to ...